Cardiovascular Ultrasound Market - Technological Advancements, Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures are the Major Factors Which Drive the Growth of Market
A key driver of the growth of the cardiovascular ultrasound market is technological advances, the benefits of echocardiography for invasive cardiac procedures, and the increased incidence of cardiovascular disease (CVD). In addition, the technology is non-invasive and widely accepted among patients, thus shortening the stay in hospitals that promote market growth.
However, market growth is hampered by factors such as new technology approvals and lack of economic compensation. Technological advances leading to cardiac-specific technologies such as tissue enhancement, lateral gain control, advanced dynamic flow, tissue Doppler and stress echoes offer manufacturers a favorable opportunity.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2827
The key players operating in the market include
• General Electric Company
• Koninklijke Philips N.V.
• TOSHIBA CORPORATION
• Hitachi Ltd.
• FUJIFILM Holdings Corporation
• Esaote SpA
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Siemens AG
• Analogic Corporation.
The global cardiovascular ultrasound market is categorized by test type, technology, device display, end user and region. Depending on the type of test, the market is classified as stress echocardiography, transthoracic echocardiography, fetal echocardiography, and transesophageal echocardiography.
Depending on the technology, it is divided into 2D, 3D and 4D and Doppler imaging. On the display side, it is divided into a color display and a monochrome (B / W) display. According to the end user, it is classified as heart center, hospital, home nursing, ambulatory care (research institute, medical device and pharmaceutical company). Geographically analyzed in North America, Europe, Asia Pacific and LAMEA.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2827
• The study provides an in-depth analysis of the cardiovascular ultrasound market with current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
• Extensive analysis of the market by devices type assists to understand the availability of various forms of devices used in cardiovascular ultrasound market.
Access Full Summery @ https://www.alliedmarketresearch.com/cardiovascular-ultrasound-market
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Ultrasound Market - Technological Advancements, Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures are the Major Factors Which Drive the Growth of Market here
News-ID: 1606204 • Views: 275
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Cardiovascular
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market Detailed Description by 2021
Cardiovascular diseases, also known as heart diseases, are diseases of heart and circulatory system. Some of the most common cardiovascular diseases are hypertensive heart disease, rheumatic heart disease, cerebrovascular heart disease, ischemic heart disease and inflammatory heart disease. Hypertensive heart disease occurs due to high blood pressure. Major problems associated with hypertensive heart disease include heart failure, hypertrophy, coronary heart disease and angina. Rheumatic heart disease is caused by rheumatic
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Market Overview of Cardiovascular Disease Industry 2018
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" globally. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313843 The most crucial risk
Medpace Implements Digisonics Solution for Cardiovascular Research
Medpace, a clinical research lab in Cincinnati, has implemented the Digisonics CVIS system for their latest cardiovascular research study. Digisonics provides Medpace’s researchers with unparalleled capabilities for image review and quantitation with over 1,100 preset measurements and an unlimited number of user defined fields as well as the ability to quickly document their findings in a comprehensive report. An additional remote reading application, DigiNet Pro, provides Medpace’s multiple users
Cardiovascular Stents Market — Trends, 2017–2025
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,